ArticleBiomarker research2021

Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC.

Weijie Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.